| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gavin P Reynolds, Belen Arranz, Lucy A Templeman, Sofia Fertuzinhos, Luis Sa. Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients. The American journal of psychiatry. vol 163. issue 10. 2006-11-06. PMID:17012696. |
a functional polymorphism in the promoter region of the 5-ht(1a) receptor gene is associated with depression and suicidal behavior. |
2006-11-06 |
2023-08-12 |
Not clear |
| Jeffrey R Bishop, Jessica Moline, Vicki L Ellingrod, Susan K Schultz, Anita H Clayto. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 10. 2006-11-01. PMID:16710319. |
serotonin 2a -1438 g/a and g-protein beta3 subunit c825t polymorphisms in patients with depression and ssri-associated sexual side-effects. |
2006-11-01 |
2023-08-12 |
Not clear |
| Jeffrey R Bishop, Jessica Moline, Vicki L Ellingrod, Susan K Schultz, Anita H Clayto. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 31. issue 10. 2006-11-01. PMID:16710319. |
it is currently unknown if functional polymorphisms in the 5ht2a receptor or its g-protein second messenger complex are related to sexual dysfunction in patients taking an selective serotonin reuptake inhibitor (ssri) for depression. |
2006-11-01 |
2023-08-12 |
Not clear |
| Katsuyoshi Mizukami, Yoshiro Tanaka, Takashi Asad. Efficacy of milnacipran on the depressive state in patients with Alzheimer's disease. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 7. 2006-10-31. PMID:16603301. |
an open-labeled study was conducted to examine the efficacy of selective serotonin and noradrenaline reuptake inhibitor (snri), milnacipran in treating depression in alzheimer's disease (ad) patients. |
2006-10-31 |
2023-08-12 |
Not clear |
| Soili Lehto, Tommi Tolmunen, Mikko Joensuu, Pirjo Irmeli Saarinen, Ritva Vanninen, Pasi Ahola, Jari Tiihonen, Jyrki Kuikka, Johannes Lehtone. Midbrain binding of [123I]nor-beta-CIT in atypical depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 7. 2006-10-31. PMID:16644083. |
altered serotonin (sert) and dopamine transporter (dat) densities have been recorded in major depression. |
2006-10-31 |
2023-08-12 |
Not clear |
| Soili Lehto, Tommi Tolmunen, Mikko Joensuu, Pirjo Irmeli Saarinen, Ritva Vanninen, Pasi Ahola, Jari Tiihonen, Jyrki Kuikka, Johannes Lehtone. Midbrain binding of [123I]nor-beta-CIT in atypical depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 7. 2006-10-31. PMID:16644083. |
atypical depression (atd) has been suggested to be connected to decreased serotonergic transmission, but no studies have been published on the association between brain serotonin transporter density and atd. |
2006-10-31 |
2023-08-12 |
Not clear |
| Edward C Suarez, K Ranga R Krishna. The relation of free plasma tryptophan to anger, hostility, and aggression in a nonpatient sample of adult men and women. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. vol 31. issue 3. 2006-10-31. PMID:16700639. |
dysregulation of central nervous system serotonergic (5-ht) activity is implicated in behavioral states and psychological traits associated with depression and aggression, with some studies suggesting possible gender-related differences. |
2006-10-31 |
2023-08-12 |
Not clear |
| Shinji Sato, Yuriko Yamakawa, Yasushi Terashima, Hitoshi Ohta, Takashi Asad. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study. Psychiatry and clinical neurosciences. vol 60. issue 5. 2006-10-24. PMID:16958942. |
the aim of this study was to assess the therapeutic efficacy of the serotonin norepinephrine reuptake inhibitor (snri), milnacipran, on both cognitive impairment and depression in post-stroke depression (psd) patients. |
2006-10-24 |
2023-08-12 |
Not clear |
| Lora K Shahine, Ruth B Lath. Night sweats and elevated follicle-stimulating hormone levels while taking selective serotonin reuptake inhibitors. Obstetrics and gynecology. vol 108. issue 3 Pt 2. 2006-10-24. PMID:17018486. |
selective serotonin reuptake inhibitors (ssris) are commonly prescribed to women with depression and anxiety disorders. |
2006-10-24 |
2023-08-12 |
Not clear |
| Daniel Baill. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents]. Presse medicale (Paris, France : 1983). vol 35. issue 9 Pt 2. 2006-10-20. PMID:16969324. |
selective serotonin reuptake inhibitors (ssris) have been used increasingly since the early 1990s to treat anxiety disorders and depression in children and adolescents. |
2006-10-20 |
2023-08-12 |
Not clear |
| Daniel Weintraub, Donna Taraborelli, Knashawn H Morales, John E Duda, Ira R Katz, Matthew B Ster. Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study. The Journal of neuropsychiatry and clinical neurosciences. vol 18. issue 3. 2006-10-19. PMID:16963587. |
depression and antidepressant use are common in parkinson's disease, but the benefit of selective serotonin reuptake inhibitor (ssri) treatment in this population has not been established. |
2006-10-19 |
2023-08-12 |
human |
| Carmen Mannucci, Michele Tedesco, Maria Bellomo, Achille P Caputi, Gioacchino Calapa. Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke. Neurochemistry international. vol 49. issue 5. 2006-10-18. PMID:16697079. |
our aim has been to investigate the links between tobacco addiction and depression by studying the long-term effects of repeated administration of nicotine followed by dependence, to forced swimming test, serotonin content and 5-ht(1a) expression in diencephalon. |
2006-10-18 |
2023-08-12 |
mouse |
| Allan V Kalueff, Pamela S Gallagher, Dennis L Murph. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. Neuroreport. vol 17. issue 12. 2006-10-18. PMID:16951583. |
although the serotonin transporter is a key target for antidepressants, its exact role in depression etiology remains unclear. |
2006-10-18 |
2023-08-12 |
mouse |
| Allan V Kalueff, Pamela S Gallagher, Dennis L Murph. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. Neuroreport. vol 17. issue 12. 2006-10-18. PMID:16951583. |
while serotonin transporter knockout mice are a potential model to examine this problem, their depression profile is unclear in several 'despair' tests, and may be confounded by their hypoactivity phenotype (confirmed here by marble-burying and bedding tests). |
2006-10-18 |
2023-08-12 |
mouse |
| Allan V Kalueff, Pamela S Gallagher, Dennis L Murph. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. Neuroreport. vol 17. issue 12. 2006-10-18. PMID:16951583. |
to assess depression in these mice, we evaluated wild-type, heterozygous, and serotonin transporter knockout c57bl/6 male mice on a well-validated, anhedonia-based depression paradigm, the sucrose preference test. |
2006-10-18 |
2023-08-12 |
mouse |
| Allan V Kalueff, Pamela S Gallagher, Dennis L Murph. Are serotonin transporter knockout mice 'depressed'?: hypoactivity but no anhedonia. Neuroreport. vol 17. issue 12. 2006-10-18. PMID:16951583. |
these results demonstrate that depression-like behavior (unlike hypoactivity) is not a baseline phenotypic feature of serotonin transporter knockout mice, suggesting anew that these mice do not represent a genetic model of depression. |
2006-10-18 |
2023-08-12 |
mouse |
| Gregory M Sullivan, J John Mann, Maria A Oquendo, Ee S Lo, Thomas B Cooper, Jack M Gorma. Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. Biological psychiatry. vol 60. issue 5. 2006-10-12. PMID:16487493. |
low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. |
2006-10-12 |
2023-08-12 |
Not clear |
| Marie Cahi. British Association for Psychopharmacology Summer Meeting: 23-26 July 2006, Oxford, United Kingdom. Expert opinion on pharmacotherapy. vol 7. issue 14. 2006-10-11. PMID:17020426. |
this report highlights selected presentations from the meeting, focusing on rapid tryptophan depletion, which is a dietary manipulation that is used to study central serotonin function and putative animal models of depression and schizophrenia. |
2006-10-11 |
2023-08-12 |
Not clear |
| Rickard L Sjöberg, Kent W Nilsson, Niklas Nordquist, John Ohrvik, Jerzy Leppert, Leif Lindström, Lars Orelan. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. The international journal of neuropsychopharmacology. vol 9. issue 4. 2006-10-10. PMID:16212676. |
development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. |
2006-10-10 |
2023-08-12 |
Not clear |
| Rickard L Sjöberg, Kent W Nilsson, Niklas Nordquist, John Ohrvik, Jerzy Leppert, Leif Lindström, Lars Orelan. Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. The international journal of neuropsychopharmacology. vol 9. issue 4. 2006-10-10. PMID:16212676. |
previous research has demonstrated that a polymorphism in the serotonin transporter gene (5-httlpr) and adverse psychosocial circumstances interact to predict depression. |
2006-10-10 |
2023-08-12 |
Not clear |